Try our Advanced Search for more refined results
Life Sciences - July, 2009
149 articles
- Judge Hits Reset Button In Cephalon Antitrust Actions
- EPA Reaches Deal With Disinfectant Maker
- Novartis Bests Defect Claims In Trileptal Suit
- Q&A With Troutman Sanders' Barry Brett
- Insurer's Class Action Over Trasylol Dismissed
- Pfizer Finalizes $75M Trovan Deal With Nigeria
- Women GCs Climb Ranks But Still Face Challenges
- FTC Fights To Block Thoratec, HeartWare Merger
- Abbott Yanks Potentially Lethal Coronary Catheters
- 1st Case To Go To Trial In Neurontin MDL Dropped
- Male Enhancement, Bodybuilding Products Recalled
- Merck Sells Merial Stake For $4B To Expedite Merger
- Abbott Appeals $29.2M C&D Pregnancy Test Verdict
- Q&A With Sheppard Mullin's Amar Thakur
- FDA Says Bodybuilding Products Contain Steroids
- Doctor Hides Ties To Medtronic At Senate Hearing
- FDA To List Mercury Dental Fillings As Moderate Risk
- Analyzing The EC's Drug Sector Inquiry Report
- Apotex Asks High Court To Hear Plavix Dispute
- KV Pharmaceutical Moves To Toss Securities Action
- Baby Formula Suit Against Abbott Survives
- FTC, Cephalon Must Refile Antitrust Motions: Judge
- Baxter Settles Ill. Drug Price Fraud Suit For $6.8M
- Merck's Bid To Block Expert Testimony Mostly Fails
- Tafas V. Doll Could Become Moot: USPTO, GSK, Tafas
- Medtronic To Pay Abbott $400M To Quell Stent Suits
- Medarex Investor Sues Over $2B Bristol-Myers Sale
- Pfizer Sets $75M Trovan Deal In Stone
- Lilly Allowed To Keep Expert Out Of Prozac Death Suit
- Wyeth's 'Medical Ghostwriting' Docs To See Daylight
- Merck, Schering Settle Investor Action Over Merger
- Yaz, Yasmin Plaintiffs Appeal To JPMDL
- USPTO Confirms KCI Wound Therapy Patents
- NY Latest To Challenge $55M Schering Deal
- New Complaint Allowed In AstraZeneca Pain Med Suit
- Teva Settles Patent Spat Over Ortho Tri-Cyclen
- Bristol-Myers Settles Plavix Securities Suit For $125M
- Digitek Judge Allows Contact With Actavis Workers
- Cordis Loses Motion For Judgment In Stent IP Case
- U. Of Pittsburgh Wins Fight Over Stem Cell Patent
- Mass. Balks At $55M Schering Price Inflation Deal
- Ohio Asst. Managers Slap Rite Aid With Overtime Suit
- Bristol-Myers To Purchase Medarex For $2.1B
- Case Over Lilly's Zyprexa Gets Booted For 2nd Time
- FDA Warns Abbott About Marketing Of HIV Drug
- Troutman Adds 5 IP Attys To New Life Sciences Team
- Invacare Sues Rival Over Hospital Bed Patents
- SEC Hits Perry With Merger Arbitrage Fine
- Lundbeck Fails To Escape NeoProfen Antitrust Suits
- Health Fund's Seroquel Complaint Booted
- Two Execs Plead Guilty In Bone Cement Deaths Case
- Solvay, Watson Say AndroGel Deals Are Legal
- Claims Survive In Citrucel Suit
- Medtronic Unit Gets $2M In Spine Surgery Patent Suit
- Plaintiffs Win Again In Seroquel MDL Experts Fight
- NM Wins Bid To Return Seroquel Suit To State Court
- Investors Sue Caraco Over Plant Inspections, Raids
- Matrixx Hit With Shareholder Action Over Zicam
- How The Supreme Court Should Resolve Bilski
- EU Approves Pfizer, Wyeth Deal With Conditions
- EU Targets Energy, Tech, Drugs For Antitrust Action
- Pro-Pharmaceuticals Shakes Off Trade Secret Claims
- $36M Trade Secrets Verdict Rushes Luna Into Ch. 11
- Young You Recalls Diet Pills Containing Sibutramine
- Inferring Intent In Inequitable Conduct Cases
- Teva Yanks Tainted Lots Of Anesthetic Propofol
- Genzyme Targets Sandoz Over Hectorol Patent
- FDA Launches Safety Review Of Asthma Drug Xolair
- Mannatech Sues Rivals Over Diet Supplement Patents
- The FDA's Approval Of Percocet And Vicodin
- Plaintiffs' Experts Nixed In Bausch ReNu Case
- Democratic Senators Rip Health Insurance Industry
- Male Enhancement Pills Containing ED Drugs Recalled
- The Risks Of Online Auctions, Counterfeit Goods
- AstraZeneca Wants Scope Narrowed In Seroquel MDL
- Merck, Schering-Plough End Vytorin Investigation
- Off-Label Marketing Claims Against Schering Tossed
- Male Enhancement Pills With Tadalafil Face Recall
- Albion, Lannett End Generic Vitamin Spat
- Device Makers Engaged In Off-Label Scheme: Suits
- Trasylol Plaintiffs Step Up Fight To See Bayer Report
- Dosage Issue Spurs Recall Of Acetaminophen Drops
- Sen. Committee Ups Health Care Fraud Penalties
- Bayer Hit With Injury, Death Suits Over Yaz, Yasmin
- FDA Requires Labeling Changes For Transplant Drugs
- Inola Loses Bid To Revive Express Scripts Case
- Appeal Set For Thwarted Seroquel Plaintiff
- 3rd Circ. Affirms FDA Ban On Ephedrine Products
- KCI Loses UK Wound-Patent Fight To Smith & Nephew
- Sens. Settle On 12-Year Exclusivity For Biologics
- Viagra MDL Judge Bars Expert From Daubert Hearing
- Counsel Fees Cut In Warner Chilcott Securities Action
- Medtronic Pulls Insulin Infusion Sets
- Travelers Must Fund Heparin Defense: Equity Firm
- Aspirin Marketing MDL Bears Down on Bayer
- Sandoz Loses Bid For Attys' Fees In Lovenox Spat
- Everett, Breckenridge Reach Deal In Vitamin Suits
- Watson Pharma Ala. AWP Case Ends In Mistrial
- Covidien Recalls Weak Batch Of Diagnostic Agent
- Purdue Must Face Alpharma OxyContin Patent Claims
- US Docs Kept Back In ObTape Discovery Dispute
- Roxane Wants DOJ Sanctioned For Spoliation
- Sun, Forest Reach Deal In Lexapro Patent Suit
- Ebewe, Sanofi Come To Terms Over Eloxatin Patent
- Canadian Federal Court Deals Blow To Pfizer
- The FTC's Stance On Generic Biologics
- Lawmakers Seek Info On Medtronic Adviser Probe
- C&D Denied Fees In $29M Abbott Pregnancy Test Suit
- CCS Medical Files For Ch. 11 With Prearranged Plan
- 9th Circ. Kills Injunction On Sale Rules For Plan B
- EU Report Announces Drugmaker Probes Over Deals
- Zicam Lawsuits Pile Up In FDA Warning's Wake
- Amgen, Immunex Settle Ill. AWP Case For $7.8M
- Injunction Denied In Tyco Trachea Tube Patent Case
- Kennedy Adds To List Of Follow-On Biologics Bills
- 9th Circ. Says No Claim Stated In Norvir Pricing Case
- Flonase Antitrust Claims Survive GSK's Dismissal Bid
- FDA Orders Stronger Warning For Propoxyphene
- EU To Reveal Antitrust Cases Against Drugmakers
- Fed. Circ. To Reconsider Tafas V. Doll
- Chantix Wrongful Death Suit Survives Bid To Toss
- Immucor, J&J Face Another Antitrust Class Action
- 'Reverse Payments' Presumptively Unlawful: DOJ
- Genzyme Takes On Sandoz Over Renagel ANDA
- Sanofi Loses Bid To Stay Launch Of Generic Eloxatin
- Seroquel Clinicians' Sexcapades Fair Game In MDL
- Takeda Sues Torrent Over Diabetes Drug Patents
- Wyeth Heads To Court Again To Protect Effexor
- UK Court Clarifies Obviousness Rule In Levaquin Suit
- Galderma Hits Lupin With Rosacea Drug Patent Suit
- Novartis Loses Glivec Patent Fight In India
- Apotex Launches Suit Over Eisai's Aricept Patents
- Last Acculink Claim Against Abbott Nixed
- 9th Circ. Vacates Marlyn Supplement Recall Order
- SF Health Plan Seeks Class Cert. In McKesson AWP Suit
- Guidant Judge Rejects 3rd Party Payor Claims Again
- Sotomayor's Approach To Antitrust
- Wyeth Wins Sanctions Against Firm In Prempro MDL
- Expanded Discovery Allowed In Actavis Digitek MDL
- Eli Lilly Wins Dismissal Of Another Zyprexa Case
- FDA Mandates Labels For Pfizer, GSK Smoker Drugs
- Forest, Lundbeck Lose Bid To Limit Lexapro Claims
- Alzheimer's Institute Sues Pfizer Over Mice Patents
- Ohio Court Says Law Bars Off-Label Abortion Pill Uses
- Howrey Absorbs IP Litigation Boutique Day Casebeer
- NLRB Erred In Nursing Home Case Ruling: DC Circ.
- Q&A With Kirkland & Ellis' Luke Dauchot
- FDA Panel Pushes Acetaminophen Painkiller Ban
- Bayer Hits Teva With Suit Over Levitra Patent